专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明授权

US5446048A Rapamycin oximes 失效
标题翻译：雷帕霉素肟
公开(公告)号：US5446048A
公开(公告)日：1995-08-29
申请号：US309816
申请日：1994-09-21
申请人： Amedeo A. Failli , Robert J. Steffan , Craig E. Caufield , David C. Hu , Alexander A. Grinfeld
发明人： Amedeo A. Failli , Robert J. Steffan , Craig E. Caufield , David C. Hu , Alexander A. Grinfeld
IPC分类号： C07D498/18 , A61K31/44
CPC分类号： C07D498/18
摘要： A compound of the structure ##STR1## wherein R.sup.1 is ##STR2## R.sup.2 is hydrogen, alkyl, alkenyl, alkynyl, trifluoromethyl, arylalkyl, or Ar;R.sup.3 is hydrogen, alkyl, alkenyl, alkynyl, trifluoromethyl, arylalkyl, or --CO.sub.2 R.sup.8 ;R.sup.4 is alkyl, alkenyl, alkynyl, trifluoromethyl, arylalkyl, Ar, aminoalkyl, thioalkyl, alkylthioalkyl, hydroxyalkyl, or --CO.sub.2 R.sup.8 ;R.sup.5 is hydrogen, alkyl, alkenyl, alkynyl, trifluoromethyl, arylalkyl, Ar, or --CO.sub.2 R.sup.8 ;R.sup.6 is hydrogen, alkyl, alkenyl, alkynyl, trifluoromethyl, arylalkyl, or Ar;R.sup.7 is alkyl, alkenyl, alkynyl, trifluoromethyl, arylalkyl, or Ar;R.sup.8 is hydrogen, alkyl, alkenyl, alkynyl, trifluoromethyl, arylalkyl, fluorenylmethyl, or Ar;Y is O or S;X is .dbd.N--O--(CH.sub.2).sub.f --Z or .dbd.N--O--Ar;Z is hydrogen, alkenyl, alkynyl, alkoxy, cyano, fluoro, trifluoromethyl, --NR.sup.5 R.sup.6, aryloxy, or Ar;Ar is aryl which may be optionally mono-, di-, or tri-substituted;a=0-4;b=0-1;c=0-4;d=0-6;e=0-6; andf=0-6;or a pharmaceutically acceptable salt thereof, with the proviso that when f is 0, Z is hydrogen and further provided that when R.sup.3 or R.sup.5 is --CO.sub.2 R.sup.8, R.sup.8 is not hydrogen which is useful as an immunosuppressive, antiinflammatory, antifungal, antiproliferative, and antitumor agent.
摘要翻译：其中R1是氢，烷基，烯基，炔基，三氟甲基，芳基烷基或Ar的结构化合物 R3是氢，烷基，烯基，炔基，三氟甲基，芳烷基或-CO2R8; R4是烷基，烯基，炔基，三氟甲基，芳基烷基，Ar，氨基烷基，硫代烷基，烷硫基烷基，羟基烷基或-CO 2 R 8; R5是氢，烷基，烯基，炔基，三氟甲基，芳基烷基，Ar或-CO 2 R 8; R6是氢，烷基，烯基，炔基，三氟甲基，芳烷基或Ar; R7是烷基，烯基，炔基，三氟甲基，芳烷基或Ar; R8是氢，烷基，烯基，炔基，三氟甲基，芳基烷基，芴基甲基或Ar; Y为O或S; X = N-O-（CH 2）f-Z或= N-O-Ar; Z是氢，烯基，炔基，烷氧基，氰基，氟，三氟甲基，-NR5R6，芳氧基或Ar; Ar是可任选被单，二或三取代的芳基; a = 0-4; b = 0-1; c = 0-4; d = 0-6; e = 0-6; 和f = 0-6; 或其药学上可接受的盐，条件是当f为0时，Z为氢，并且还提供当R3或R5为-CO2R8时，R8不为氢，可用作免疫抑制，抗炎，抗真菌，抗增殖和抗肿瘤代理商

2. 发明授权

US5130307A Aminoesters of rapamycin 失效
标题翻译：雷帕霉素的氨基酯
公开(公告)号：US5130307A
公开(公告)日：1992-07-14
申请号：US657294
申请日：1991-02-19
申请人： Amedeo A. Failli , Craig E. Caufield , Robert J. Steffan
发明人： Amedeo A. Failli , Craig E. Caufield , Robert J. Steffan
IPC分类号： A61K38/00 , C07D498/18 , C07H19/01 , C07K5/06
CPC分类号： C07D498/18 , C07H19/01 , C07K5/06026 , A61K38/00
摘要： A compound of the structure ##STR1## wherein R.sup.1 and R.sup.2 are each, independently, hydrogen or ##STR2## with the proviso that R.sup.1 and R.sup.2 are not both hydrogen; R.sup.3 is hydrogen, alkyl, aralkyl, --(CH.sub.2).sub.q CO.sub.2 R.sup.6,--(CH.sub.2).sub.r NR.sup.7 CO.sub.2 R.sup.8, carbamylalkyl, aminoalkyl, hydroxyalkyl, guanylalkyl, mercaptoalkyl, alkylthioalkyl, indolylmethyl, hydroxyphenyklmethyl, imidazoylmethyl or phenyl which is optionally mono-, di-, or tri-substituted with a sustituent selected from alkyl, alkoxy, hydroxy, cyano, halo, nitro, carbalkoxy, trifluoromethyl, amino, or a carboxylic acid;R.sup.4 and R.sup.7 are each, independently, hydrogen, alkyl, or aralkyl;R.sup.5, R.sup.6, and R.sup.8 are each, indpendently, alkyl, aralkyl, fluorenylmethyl, or phenyl which is optionally mono-, di-, or tri-substituted with a substituent selected from alkyl, alkoxy, hydroxy, cyano, halo, nitro, carbalkoxy, trifluoromethyl, amino, or a carboxylic acid;m is 0-4;n is 0-4;p is 1-2;q is 0-4;r is 0-4;wherein R.sup.3, R.sup.4, m, and n are independent in each of the ##STR3## subunits when p=2; or a pharmaceutically acceptable salt thereof, which by virtue of its immunosuppressive activity is useful in treating transplantation rejection, host vs. graft disease, autoimmune diseases, and diseases of inflammation, and by virtue of its antifungal activity is useful in treating fungal infections.
摘要翻译：结构的化合物，其中R1和R2各自独立地为氢或“IMAGE”，条件是R1和R2不同时为氢; R3是氢，烷基，芳烷基， - （CH2）rNR7CO2R8，氨基甲酰基烷基，氨基烷基，羟基烷基，脒基烷基，巯基烷基，烷基硫代烷基，吲哚甲基，羟基苯甲酮，咪唑基甲基或苯基，其任选是单 - ，二 - 或三被选自烷基，烷氧基，羟基，氰基，卤素，硝基，烷氧基，三氟甲基，氨基或羧酸的取代基取代; R 4和R 7各自独立地为氢，烷基或芳烷基; R5，R6和R8各自独立地是烷基，芳烷基，芴基甲基或苯基，其任选被选自烷基，烷氧基，羟基，氰基，卤素，硝基，烷氧基中的取代基单，二或三取代，三氟甲基，氨基或羧酸; m为0-4; n为0-4; p是1-2; q为0-4; r为0-4; 当p = 2时，R 3，R 4，m和n在每个亚基中是独立的; 或其药学上可接受的盐，其由于其免疫抑制活性可用于治疗移植排斥反应，宿主与移植物疾病，自身免疫疾病和炎症疾病，并且由于其抗真菌活性可用于治疗真菌感染。

3. 发明授权

US5830911A Pyranoindole and tetrahydrocarbazole inhibitors of COX-2 失效
标题翻译：吡咯并吲哚和COX-2的四氢咔唑抑制剂
公开(公告)号：US5830911A
公开(公告)日：1998-11-03
申请号：US906361
申请日：1997-08-05
申请人： Amedeo A. Failli , Robert J. Steffan , Anthony F. Kreft , Thomas J. Caggiano , Craig E. Caufield
发明人： Amedeo A. Failli , Robert J. Steffan , Anthony F. Kreft , Thomas J. Caggiano , Craig E. Caufield
IPC分类号： C07D209/88 , C07D491/04 , A61K31/40 , C07D209/86
CPC分类号： C07D491/04 , C07D209/88
摘要： This invention provides compounds of formula I having the structure ##STR1## wherein R is (CH.sub.2).sub.n COOR.sup.4 ; R.sup.1 is hydrogen, alkyl, alkenyl, alkynyl, alkylcycloalkyl, and alkoxyalkyl; R.sup.4 is hydrogen or alkyl; R.sup.5, R.sup.6, R.sup.7, and R.sup.8 are each, independently, hydrogen, halogen, alkyl, alkenyl, alkynyl, alkoxy, arylalkoxy, fluoroalkoxy, alkylthio, alkylsulfinyl, alkylsulfonyl, cyano, nitro, --SCF.sub.3, --COR.sup.3, alkanoyloxy, hydroxy, trifluoromethyl, amino, alkylamino, dialkylamino, alkylamido, or alkylsulfonamido; wherein at least one of R.sup.5, R.sup.6, R.sup.7, or R.sup.8 is cyano; R.sup.3 is alkyl, hydroxy, alkoxy, amino, alkylamino; X is --O-- or --C--; and n=1-4 or a pharmaceutically acceptable salt thereof, which are useful in the treatment of arthritic disorders, colorectal cancer, and Alzheimer's disease.
摘要翻译：本发明提供具有结构图1的式I化合物，其中R是（CH 2）n COOR 4; R1是氢，烷基，烯基，炔基，烷基环烷基和烷氧基烷基; R4是氢或烷基; R5，R6，R7和R8各自独立地为氢，卤素，烷基，烯基，炔基，烷氧基，芳基烷氧基，氟烷氧基，烷硫基，烷基亚磺酰基，烷基磺酰基，氰基，硝基，-SCF3，-COR3，烷酰氧基，羟基，，氨基，烷基氨基，二烷基氨基，烷基酰氨基或烷基磺酰氨基; 其中R 5，R 6，R 7或R 8中的至少一个为氰基; R3是烷基，羟基，烷氧基，氨基，烷基氨基; X是-O-或-C-; 和n = 1-4或其药学上可接受的盐，其可用于治疗关节炎疾病，结肠直肠癌和阿尔茨海默氏病。

4. 发明授权

US5373014A Rapamycin oximes 失效
标题翻译：雷帕霉素肟
公开(公告)号：US5373014A
公开(公告)日：1994-12-13
申请号：US134237
申请日：1993-10-08
申请人： Amedeo A. Failli , Robert J. Steffan , Craig E. Caufield , David C. Hu , Alexander A. Grinfeld
发明人： Amedeo A. Failli , Robert J. Steffan , Craig E. Caufield , David C. Hu , Alexander A. Grinfeld
IPC分类号： C07D498/18 , A61K31/395 , C07D491/16
CPC分类号： C07D498/18
摘要： A compound of the structure ##STR1## wherein R.sup.1 is ##STR2## R.sup.2 is hydrogen, alkyl, alkenyl, alkynyl, trifluoromethyl, arylalkyl, or Ar;R.sup.3 is hydrogen, alkyl, alkenyl, alkynyl, trifluoromethyl, arylalkyl, or --CO.sub.2 R.sup.8 ;R.sup.4 is alkyl, alkenyl, alkynyl, trifluoromethyl, arylalkyl, Ar, aminoalkyl, thioalkyl, alkylthioalkyl, hydroxyalkyl, or --CO.sub.2 R.sup.8 ;R.sup.5 is hydrogen, alkyl, alkenyl, alkynyl, trifluoromethyl, arylalkyl, At, or --CO.sub.2 R.sup.8 ;R.sup.6 is hydrogen, alkyl, alkenyl, alkynyl, trifluoromethyl, arylalkyl, or Ar;R.sup.7 is alkyl, alkenyl, alkynyl, trifluoromethyl, arylalkyl, or Ar;R.sup.8 is hydrogen, alkyl, alkenyl, alkynyl, trifluoromethyl, arylalkyl, fluorenylmethyl, orAr;Y is O or S;X is .dbd.N--O--(CH.sub.2).sub.f --Z or .dbd.N--O--Ar;Z is hydrogen, alkenyl, alkynyl, alkoxy, cyano, fluoro, trifluoromethyl, --NR.sup.5 R.sup.6, aryloxy, or Ar;Ar is aryl which may be optionally mono-, di-, or tri- substituted;a=0-4;b=0-1;c=0-4;d=0-6;e=0-6; andf=0-6;or a pharmaceutically acceptable salt thereof, with the proviso that when f is 0, Z is hydrogen and further provided that when R.sup.3 or R.sup.5 is --CO.sub.2 R.sup.8, R.sup.8 is not hydrogen which is useful as an immunosuppressive, antiinflammatory, antifungal, antiproliferative, and antitumor agent.
摘要翻译：其中R1是氢，烷基，烯基，炔基，三氟甲基，芳烷基或Ar的结构化合物 R3是氢，烷基，烯基，炔基，三氟甲基，芳烷基或-CO2R8; R4是烷基，烯基，炔基，三氟甲基，芳基烷基，Ar，氨基烷基，硫代烷基，烷硫基烷基，羟基烷基或-CO 2 R 8; R5是氢，烷基，烯基，炔基，三氟甲基，芳烷基，At或-CO2R8; R6是氢，烷基，烯基，炔基，三氟甲基，芳烷基或Ar; R7是烷基，烯基，炔基，三氟甲基，芳烷基或Ar; R8是氢，烷基，烯基，炔基，三氟甲基，芳基烷基，芴基甲基或Ar; Y为O或S; X = N-O-（CH 2）f-Z或= N-O-Ar; Z是氢，烯基，炔基，烷氧基，氰基，氟，三氟甲基，-NR5R6，芳氧基或Ar; Ar是可任选被单，二或三取代的芳基; a = 0-4; b = 0-1; c = 0-4; d = 0-6; e = 0-6; 和f = 0-6; 或其药学上可接受的盐，条件是当f为0时，Z为氢，并且还提供当R3或R5为-CO2R8时，R8不为氢，可用作免疫抑制，抗炎，抗真菌，抗增殖和抗肿瘤代理商

5. 发明授权

US5023264A Rapamycin oximes 失效
标题翻译：雷帕霉素肟
公开(公告)号：US5023264A
公开(公告)日：1991-06-11
申请号：US553720
申请日：1990-07-16
申请人： Craig E. Caufield , Amedeo A. Failli
发明人： Craig E. Caufield , Amedeo A. Failli
IPC分类号： C07D498/18 , C07H19/01
CPC分类号： C07D498/18 , C07H19/01
摘要： A derivative of rapamycin in which the 27-position has the structure ##STR1## wherein R.sup.1 is hydrogen, alkyl, or --CH.sub.2 Ar;Ar is ##STR2## wherein R.sup.2, R.sup.3, and R.sup.4 are each, independently, hydrogen, alkyl, aralkyl, alkoxy, hydroxy, cyano, halo, nitro, carbalkoxy, trifluoromethyl, amino, or a carboxylic acid;X is N, O, or S;or a pharmaceutically acceptable salt thereof, which is by virtue of its immunosuppresive activity is useful in treating transplantation rejection host vs. graft disease, autoimmune diseases, and diseases of inflammation.
摘要翻译：雷帕霉素的衍生物，其中27位具有结构，其中R 1是氢，烷基或-CH 2 Ar; Ar是其中R 2，R 3和R 4各自独立地是氢，烷基，芳烷基，烷氧基，羟基，氰基，卤素，硝基，烷氧基，三氟甲基，氨基或羧酸。 X是N，O或S; 或其药学上可接受的盐，其由于其免疫抑制活性可用于治疗移植排斥宿主与移植物疾病，自身免疫疾病和炎症疾病。

6. 发明授权

US5824699A Carbazole inhibitors of Cox-2 失效
标题翻译： Cox-2的咔唑抑制剂
公开(公告)号：US5824699A
公开(公告)日：1998-10-20
申请号：US39871
申请日：1998-03-16
申请人： Anthony F. Kreft , Craig E. Caufield , Amedeo A. Failli , Thomas J. Caggiano , Alexander A. Greenfield , Dennis M. Kubrak
发明人： Anthony F. Kreft , Craig E. Caufield , Amedeo A. Failli , Thomas J. Caggiano , Alexander A. Greenfield , Dennis M. Kubrak
IPC分类号： C07D209/86 , C07D491/04 , C07D491/052 , A61K31/40 , C07D209/82
CPC分类号： C07D491/04 , C07D209/86
摘要： This invention provides compounds of formula I having the structure ##STR1## wherein R.sub.1, R.sub.2, R.sub.3 and R.sub.4 are, each, independently, hydrogen, alkyl, alkenyl, alkynyl, alkoxy, aralkoxy, trifluroalkoxy, alkanoyloxy, hydroxy, halo, trifluoromethyl, cyano, amino, mono- or di-alkylamino, alkanamido, or alkanesulfonamido; R.sub.5 is hydrogen, alkyl, alkenyl, alkoxyalkyl or alkylcycloalkyl; R.sub.6 is hydrogen, alkyl or alkenyl; X is oxygen or carbon; A is oxygen or NZ; Z is hydroxyl, alkoxy, aryloxy, carboxyalkyloxy of 2-7 carbon atoms, arylamino, or alkylsulfonyamino of 1-6 carbon atoms; or a pharmaceutically acceptable salt thereof, which are useful in the treatment of arthritic disorders, colorectal cancer, and Alzheimer's disease.
摘要翻译：本发明提供具有结构式I的式I化合物，其中R 1，R 2，R 3和R 4各自独立地为氢，烷基，烯基，炔基，烷氧基，芳烷氧基，三氟烷氧基，烷酰氧基，羟基，卤素，三氟甲基，氰基，氨基，单 - 或二 - 烷基氨基，烷酰氨基或烷磺酰氨基; R5是氢，烷基，烯基，烷氧基烷基或烷基环烷基; R6是氢，烷基或烯基; X是氧或碳; A是氧气或NZ; Z为2-7个碳原子的羟基，烷氧基，芳氧基，羧基烷氧基，芳基氨基或1-6个碳原子的烷基磺酰氨基; 或其药学上可接受的盐，其可用于治疗关节炎疾病，结肠直肠癌和阿尔茨海默氏病。

7. 发明授权

US5776967A Pyranoindole inhibitors of COX--2 失效
标题翻译： COX-2的吡喃吲哚抑制剂
公开(公告)号：US5776967A
公开(公告)日：1998-07-07
申请号：US888983
申请日：1997-07-07
申请人： Anthony F. Kreft , Craig E. Caufield , Amedeo A. Failli , Thomas J. Caggiano , Alexander A. Greenfield , Dennis M. Kubrak
发明人： Anthony F. Kreft , Craig E. Caufield , Amedeo A. Failli , Thomas J. Caggiano , Alexander A. Greenfield , Dennis M. Kubrak
IPC分类号： C07D209/86 , C07D491/04 , C07D491/052 , A61K31/40 , A61K31/35 , C07D209/80 , C07D311/78
CPC分类号： C07D491/04 , C07D209/86
摘要： This invention provides compounds of formula I having the structure ##STR1## wherein R.sub.1, R.sub.2, R.sub.3 and R.sub.4 are, each, independently, hydrogen, alkyl, alkenyl, alkynyl, alkoxy, aralkoxy, trifluroalkoxy, alkanoyloxy, hydroxy, halo, trifluoromethyl, cyano, amino, mono- or di-alkylamino, alkanamido, or alkanesulfonamido; R.sub.5 is hydrogen, alkyl, alkenyl, alkoxyalkyl or alkylcycloalkyl; R.sub.6 is hydrogen, alkyl or alkenyl; X is oxygen or carbon; A is oxygen or NZ; Z is hydroxyl, alkoxy, aryloxy, carboxyalkyloxy of 2-7 carbon atoms, arylamino, or alkylsulfonyamino of 1-6 carbon atoms; or a pharmaceutically acceptable salt thereof, which are useful in the treatment of arthritic disorders, colorectal cancer, and Alzheimer's disease.
摘要翻译：本发明提供具有结构式I的式I化合物，其中R 1，R 2，R 3和R 4各自独立地为氢，烷基，烯基，炔基，烷氧基，芳烷氧基，三氟烷氧基，烷酰氧基，羟基，卤素，三氟甲基，氰基，氨基，单 - 或二 - 烷基氨基，烷酰氨基或烷磺酰氨基; R5是氢，烷基，烯基，烷氧基烷基或烷基环烷基; R6是氢，烷基或烯基; X是氧或碳; A是氧气或NZ; Z为2-7个碳原子的羟基，烷氧基，芳氧基，羧基烷氧基，芳基氨基或1-6个碳原子的烷基磺酰氨基; 或其药学上可接受的盐，其可用于治疗关节炎疾病，结肠直肠癌和阿尔茨海默氏病。

8. 发明授权

US06686476B2 Substituted 1-aryl-3-heteroaryl-thioureas and substituted 1-aryl-3-heteroaryl-isothioureas as antiatherosclerotic agents 失效
标题翻译：新型取代的1-芳基-3-杂芳基硫脲和取代的1-芳基-3-杂芳基 - 异硫脲作为抗动脉粥样硬化剂
公开(公告)号：US06686476B2
公开(公告)日：2004-02-03
申请号：US10212888
申请日：2002-08-06
申请人： Robert J. Steffan , Amedeo A. Failli
发明人： Robert J. Steffan , Amedeo A. Failli
IPC分类号： C07D27728
CPC分类号： C07D275/03 , A61K31/415 , C07D231/40 , C07D263/48 , C07D277/48 , C07D277/82 , C07D277/84 , C07D285/135
摘要： Antiatherosclerotic agents are provided which are represented by Formulas I or II: wherein R is wherein R9, R10, R11, R12, R13, and R14 are each, independently, hydrogen or a lower alkyl of 1-6 carbon atoms; R6, and R7 are each, independently, hydrogen, lower alkyl of 1-6 carbon atoms, or CH2COOR8, where R8 is a lower alkyl of 1-6 carbon atoms; and X is O or S; R1 is hydrogen or a lower alkyl of 1-6 carbon atoms; R2, R3, and R4 are each, independently, hydrogen or halogen; and R5 is a lower alkyl of 1-6 carbon atoms; or a pharmaceutically acceptable salt thereof.
摘要翻译：提供由式I或II表示的抗动脉粥样硬化剂：其中R在其中R 9，R 10，R 11，R 12，R 13和R 14各自独立地为氢或1-6个碳原子的低级烷基; R 6和R 7各自为独立地是氢，1-6个碳原子的低级烷基或CH2COOR8，其中R8是1-6个碳原子的低级烷基; 且X为O或S; R 1为氢或1-6个碳原子的低级烷基; R 2，R 3和R 4各自独立地为氢或卤素; 和R 5是1-6个碳原子的低级烷基;或其药学上可接受的盐。

9. 发明授权

US5260299A Rapamycin 42-sulfonates and 42-(N-Carboalkoxy)Sulfamates Useful as Immunosuppressive Agents 失效
标题翻译：雷帕霉素42-磺酸盐和42-（N-羧基烷氧基）磺酸盐可用作免疫抑制剂
公开(公告)号：US5260299A
公开(公告)日：1993-11-09
申请号：US917555
申请日：1992-07-21
申请人： Amedeo A. Failli , Wenling Kao , Robert J. Steffan , Robert L. Vogel
发明人： Amedeo A. Failli , Wenling Kao , Robert J. Steffan , Robert L. Vogel
IPC分类号： C07D498/18 , A61K31/395
CPC分类号： C07D498/18
摘要： A derivative of rapamycin of general formula (I) ##STR1## where R.sup.1 is alkyl, alkenyl, or alkynyl containing 1 to 6 carbon atoms; or an aromatic moiety selected from the group consisting of phenyl and naphthyl or a heterocyclic moiety selected from the group consisting of thiophenyl and quinolinyl or NHCO.sub.2 R.sup.2 wherein R.sup.2 is lower alkyl containing 1 to 6 carbon atoms or a pharmaceutically acceptable salt thereof, which by virtue of its immunosuppressive activity is useful in treating transplantation rejection, host versus graft disease, autoimmune diseases, and diseases of inflammation.
摘要翻译：通式（I）的雷帕霉素的衍生物其中R 1是含有1至6个碳原子的烷基，烯基或炔基; 或选自苯基和萘基的芳族部分或选自噻吩基和喹啉基或NHCO 2 R 2的杂环部分，其中R 2是含有1至6个碳原子的低级烷基或其药学上可接受的盐，其由于其免疫抑制活性可用于治疗移植排斥反应，宿主与移植物疾病，自身免疫疾病和炎症疾病。

10. 发明授权

US5177203A Rapamycin 42-sulfonates and 42-(N-carboalkoxy) sulfamates useful as immunosuppressive agents 失效
标题翻译：雷帕霉素42-磺酸盐和42-（N-烷氧羰基）氨基磺酸盐可用作免疫抑制剂
公开(公告)号：US5177203A
公开(公告)日：1993-01-05
申请号：US846637
申请日：1992-03-05
申请人： Amedeo A. Failli , Wenling Kao , Robert J. Steffan , Robert L. Vogel
发明人： Amedeo A. Failli , Wenling Kao , Robert J. Steffan , Robert L. Vogel
IPC分类号： C07D498/18
CPC分类号： C07D498/18
摘要： A derivative of rapamycin of general formula (I) ##STR1## where R.sup.1 is alkyl, alkenyl, or alkynyl containing 1 to 6 carbon atoms; or an aromatic moiety selected from the group consisting of phenyl and naphthyl or a heterocyclic moiety selected from the group consisting of thiophenyl and quinolinyl or NHCO.sub.2 R.sup.2 wherein R.sup.2 is lower alkyl containing 1 to 6 carbon atoms or a pharmaceutically acceptable salt thereof, which by virtue of its immunosuppressive activity is useful in treating transplantation rejection, host versus graft disease, autoimmune diseases, and diseases of inflammation.
摘要翻译：通式（I）的雷帕霉素的衍生物其中R 1是含有1至6个碳原子的烷基，烯基或炔基; 或选自苯基和萘基的芳族部分或选自噻吩基和喹啉基或NHCO 2 R 2的杂环部分，其中R 2是含有1至6个碳原子的低级烷基或其药学上可接受的盐，其由于其免疫抑制活性可用于治疗移植排斥反应，宿主与移植物疾病，自身免疫疾病和炎症疾病。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式